Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2014 for NF2 Patients With Progressive or Symptomatic Meningiomas
NCT02831257Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vistusertib in meningioma, sponsored by Massachusetts General Hospital. Started Aug 2016; status: completed.
02
Drugs
vistusertib
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT02831257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831257.